Berlin (dpa) – As bowel cancer becomes more common among people in their 50s and younger, concerns about early-onset have been magnified by the disease’s growing resistance to chemotherapy. But in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)